Neuroparticle Corporation to Present at the Biotech Showcase™ Annual Conference on January 9, 2018
Bethesda Maryland, December 28, 2017 – Neuroparticle Corporation President Dr. Lamar Mair, today announced that it will present at Biotech Showcase ™ 2018, to be held January 8–10 during the most important week in healthcare at the Hilton San Francisco Union Square.
Dr. Irving Weinberg will present at the Biotech Showcase™ as follows:
Date: January 9, 2018
Time: 2:30 PM (PST)
Room: Franciscan D
Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA (United States)
Neuroparticle Corporation has developed a patented non-invasive MRI-guided platform for delivering therapy to the brain and other organs. Rotating magnetic particles carrying electrical or chemical payloads can be targeted to specific locations deep in the body, bypassing the blood-brain barrier. Initial clinical targets include addiction and chronic pain, with eventual applications to brain-machine interface and enhanced cognition.
Biotech Showcase™, produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference.
Sara Demy-Colton, CEO of Demy-Colton, said: “We are delighted that Neuroparticle Corporation will be presenting at Biotech Showcase this year. Biotech Showcase is the perfect platform for life science companies to showcase their innovation and seek out their next deal. This year again we are thrilled to be hosting what we believe will be the great business development opportunity of 2018.”
Additional links and information: